Filter
1986
Filtered Results: 1986
Text search:
registration
of
drugs
Featured
Recommendations
162
New Publications
660
Language
Document type
No document type
1313
Studies & Reports
249
Guidelines
212
Manuals
85
Strategic & Response Plan
74
Training Material
20
Fact sheets
17
Situation Updates
11
Resource Platforms
4
Brochures
1
Countries / Regions
India
194
Kenya
78
Uganda
55
Ethiopia
50
Sierra Leone
49
South Africa
47
Global
47
Nigeria
46
Nepal
45
Ghana
42
Tanzania
41
Bangladesh
41
Malawi
40
Rwanda
38
Liberia
36
Western and Central Europe
35
Myanmar / Burma
33
Namibia
29
Africa
29
Ukraine
28
Zambia
26
Latin America and the Carribbean
20
Philippines
19
Cambodia
19
Botswana
19
Eastern Europe
19
Zimbabwe
17
Syria
17
Lesotho
15
Indonesia
14
South–East Asia Region
14
Asia
14
South Sudan
13
Congo, Democratic Republic of
11
Mozambique
11
Eswatini/ Swaziland
8
Colombia
7
Senegal
6
Pakistan
6
Sudan
6
West and Central Africa
6
Tajikistan
6
Russia
6
East and Southern Africa
5
Moldova
5
Haiti
4
Jordan
4
Lebanon
4
Benin
4
Brazil
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Venezuela
4
Albania
4
Cameroon
3
Iraq
3
Afghanistan
3
Germany
3
Argentina
3
North Macedonia
3
Libya
3
Sri Lanka
3
Chile
3
Paraguay
3
Iran
3
Georgia
3
United Kingdom
3
Burkina Faso
2
Saudi Arabia
2
Thailand
2
Papua New Guinea
2
Central African Republic
2
Bolivia
2
Greece
2
Angola
2
Western Pacific Region
2
Bhutan
2
Poland
2
Palestine
2
Armenia
2
Laos
2
Timor Leste/ East Timor
2
Romania
2
Uruguay
2
Turkmenistan
2
Guinea
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Somalia
1
Egypt
1
Gambia
1
China
1
Malaysia
1
Ireland
1
Singapore
1
Peru
1
Ecuador
1
Madagascar
1
Yemen
1
Fiji
1
Italy
1
Djibouti
1
Qatar
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
North America
1
Denmark
1
Maldives
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
1027
Clinical Guidelines
147
Public Health
95
Women & Child Health
73
Key Resources
41
Pharmacy & Technologies
36
Capacity Building
23
Toolboxes
TB
190
HIV
175
Mental Health
90
AMR
78
Pharmacy
78
COVID-19
73
Conflict
53
NTDs
44
Caregiver
38
Refugee
35
NCDs
33
Disability
31
Rapid Response
21
Global Health Education
16
Ebola
15
Natural Hazards
13
Planetary Health
10
Specific Hazards
8
Health Financing Toolbox
6
Polio
5
Cholera
4
Social Ethics
4
Zika
3
South Sudan
2
Policy note: Cambodia Health Systems in Transition.
The health system includes a mix of public and private providers. The use of private providers is much greater among the wealthy, while the u...
The health system includes a mix of public and private providers. The use of private providers is much greater among the wealthy, while the u...
This report presents country, regional and global estimates of low birth weight for 2000, together with a detailed description of the methods used in calculating the estimates. Some limited data on ...
Joint EUAA, IOM and OECD report provides new insights on displacement from and within Ukraine
The European Union Agency for Asylum (EUAA), the International Organization for Migration (IOM) and the Organisation for Economic Co-operation and Development (OECD) have published a Joint Report on profil...
UNAIDS 2018 / Guidance
Guidance for policy-makers, and people living with, at risk of or affected by HIV
Version 2, January 2016
The primary purpose of this document is to provide 3MDG stakeholders with some essential information on the MNCH core-indicators for 3MDG, which were derived from the 3MDG Logical Framework, Data Dictionary for Health S... (2014 June, DoPH, MoH), A Guide for Monitoring and Evaluating Child Health Programmes (MEASURE Evaluation, September 2005) and Monitoring Emergency Obstetric Care (WHO/UNICEF/UNFPA/AMDD). Partners are strongly encouraged to integrate the MNCH indicators into their ongoing monitoring and evaluation (M&E) activities.
These indicators are designed to help Partners assess the current state of their activities, their progress towards achieving their targets, and contribution towards the national response. This guideline is designed to improve the quality and consistency of data collected at the township level, which will enhance the accuracy of conclusions drawn when the data are aggregated.
The primary purpose of this document is to provide 3MDG stakeholders with some essential information on the MNCH core-indicators for 3MDG, which were derived from the 3MDG Logical Framework, Data Dictionary for Health S... (2014 June, DoPH, MoH), A Guide for Monitoring and Evaluating Child Health Programmes (MEASURE Evaluation, September 2005) and Monitoring Emergency Obstetric Care (WHO/UNICEF/UNFPA/AMDD). Partners are strongly encouraged to integrate the MNCH indicators into their ongoing monitoring and evaluation (M&E) activities.
These indicators are designed to help Partners assess the current state of their activities, their progress towards achieving their targets, and contribution towards the national response. This guideline is designed to improve the quality and consistency of data collected at the township level, which will enhance the accuracy of conclusions drawn when the data are aggregated.
Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However, diphtheria is still prevalent in several countries and areas ... the Region and remains a public health issue due to its high case fatality rate.
This Field Guide for Preparedness and Response to Diphtheria Outbreaks in the Western Pacific Region is a reference resource for Member States to develop national guidelines adapted to their local context. Countries may also use this Guide to facilitate outbreak preparedness and public health responses to reduce morbidity and mortality due to diphtheria.
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management ... CVD diseases. Affordable essential medicines and technologies to manage CVD disease must be available where and when they are required. Medicines and technologies need to be managed appropriately to ensure that the correct medicines are selected, procured in the right quantities, distributed to facilities in a timely manner, and handled and stored in a way that maintains their quality. This needs to be backed up by policies that enable sufficient quantities to be procured in order to reduce cost inefficiencies, ensure the reliability and security of the distribution system, and encourage the appropriate use of these health products. In order to avoid stock-outs and the disruption of treatment, all related activities need to be conducted in a timely manner, with performance continually monitored, and prompt action taken in response to problems that may arise. Additionally, medication must be dispensed correctly and used rationally by the healthcare provider and patient alike. The purpose of this guide is to explain the necessary steps.
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, howeve...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries ... Asia and Africa. It often affects people with impaired immunity, including people living with HIV, among whom the most frequent clinical presentation is disseminated histoplasmosis. The symptoms of disseminated histoplasmosis are non-specific and may be indistinguishable from those of other infectious diseases, especially disseminated tuberculosis (TB), thus complicating diagnosis and treatment. Histoplasmosis is one of the most frequent opportunistic infections caused by fungal pathogens among people living with HIV in the Americas and may be responsible for 5–15% of AIDS-related deaths every year in this Region. These guidelines aim to provide recommendations for the diagnosis, treatment, and management of disseminated histoplasmosis in persons living with HIV
The 2019 SLDHS is a national sample survey that provides up-to-date information on demographic and health indicators. The sample was selected using a stratified, two-stage cluster design, with enumeration areas (EAs) as the sampling units for the first stage. The second stage was a complete listing ...
A national overview with a case study from Tanahun district. The overall aims of this study are (1) to assess the extent to which social protection systems in Nepal address the needs of people with ...
The health sector In Ukraine is beginning to change in recent years. The sector, based on a system of health care (Semashko) originating from the Soviet Union, had been stagnant for many years. Remarkably little had changed since Independence and th...
The military offensive by the Russian Federation in Ukraine which began February 2022 has triggered one of the world’s fastest-growing displacement and humanitarian crisis, with geopolitical and economic ripples felt across the globe. The ongoing ...
This Framework offers a coherent approach for eliminating tuberculosis (TB) in low-incidence countries. It is designed to guide national policy-makers and those responsible for technical aspects of the national TB response in accelerating efforts to...
As the culminating volume in the DCP3 series, volume 9 will provide an overview of DCP3 findings and methods, a summary of messages and substantive lessons to be taken from DCP3, and a further discu...
This guide is strongly practice -oriented and intended as an open resource when replicating similar methods of psychosocial care in other projects. It describes the steps in the development of... our pilot project
"Low threshold psychosocial support for refugees and asylum seekers’ in Germany ", from the initial idea of the project to its practical implementation. It is to be understood as apractical report for transferring the working methods of MSF from project countries to the German context. A particular focus is the training and working methods of psychosocial peer counsellors. They are at the heart of our approach to low-
threshold psychosocial care
The HEARTS technical package provides a strategic approach to improving cardiovascular health in countries. It comprises six modules and an implementation guide. This package supports Ministries of Health to strengthen CVD management in primary heal...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In ad...
In India, in response to the above and guided by our counterparts in the government of India, the UN agencies have developed the Novel Coronavirus Disease Joint Health Response Plan by UN Agencies and Partners, led by WHO-India, in close collaborati...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions ... access to HCV diagnostics and pharmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners.
